Home › Essential Tremor › NCT05897775
Coordinated Reset Deep Brain Stimulation for Essential Tremor
Who can join
Ages 21 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosis of essential tremor (ET) * Age of 21 or over * Will be or has been implanted with Boston Scientific Vercise Rechargeable Genus deep brain stimulation (DBS) system * 7 Tesla (7T) MRI pre-operative scan under Noam Harel PhD's Center for Magnetic Research (University of Minnesota IRB #1210M22183) protocol "Imaging of DBS targets at 7T MRI" * Planned post-operative CT scan Exclusion Criteria: * History of musculoskeletal disorders that affect movement of the limbs or gait * Other significant neurological disorder * History of dementia or cognitive impairment that precludes them from getting DBS surgery * Significant psychiatric disease * On medication that could cause tremor * Prior brain surgery * Pregnant women * Evidence of non-ET central nervous system disease or injury for at least three (3) months prior to implantation * Any suspicion of Parkinsonian tremor, including presence of Parkinsonian features such as bradykinesia, rigidity, or postural instability * Other significant medical disorder that could impede study participation
About the study
Deep brain stimulation (DBS) is a surgical procedure for the treatment of Essential Tremor (ET). A novel approach to current DBS approaches is called coordinated reset DBS (CR-DBS) which uses different patterns of stimulation at lower currents and can address the limitations of traditional DBS that uses continuous high amplitude, high frequency stimulation. This study will evaluate the feasibility, safety and short-term efficacy of thalamic CR-DBS in upper extremity ET. The goal of this study is to evaluate the safety and short-term efficacy of thalamic CR- DBS in ET, including the acute (during CR-DBS) and carryover (following DBS cessation) effects, and compare these to those induced by clinically optimized T-DBS. To achieve our goal, a low-risk, two-phase clinical study will be conducted in patients with upper extremity (UE) ET. The first aim is to identify the spatial location and peak frequency of tremor related oscillatory activities in VIM (Phase I). The second aim is to compare the acute effects of thalamic CR-DBS to clinically optimized T-DBS (Phase II).
What is being tested
- Deep brain stimulation (device)
Sponsor: University of Minnesota · Participants: 23 · Started: Sep 11, 2023
Contact the study team
- Jing Wang, PhD · Phone: (612) 626-6071
- Selam Woldegerima · Phone: (763) 347-1287
Official record on ClinicalTrials.gov — NCT05897775
Locations in the U.S.
| Minnesota | University of Minnesota, Minneapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.